In addition, we demonstrated that underlying the oncogenic and HCC-promoting activity of SAE1 was its ability to upregulate oncogenic effectors of cell cycle progression while downregulating FOXO1-associated tumor suppressing signaling. The gene discussed is FOXO1; the disease is hepatocellular carcinoma.